Posts Tagged ‘Revance Therapeutics’

Cosmetic medicine developers test Botox alternative

Monday, December 1st, 2008

As Allergan-made Botox continues to gain in popularity, competitors in the non-surgical cosmetic treatment market are stepping up their efforts to offer a suitable alternative.

One biopharmaceutical company that specialises in aesthetic medicine, Revance Therapeutics, has just secured $8 million worth of financing in order to help with the clinical development of ST0001, a topical form botulinum toxin type A that could be a rival to the wrinkle-relaxing injection. (more…)